Profound Medical Corp's stock has seen a notable uptick, closing up 2.07% as investors respond positively to its recent performance.
In the latest trading session, Profound Medical Corp (PRN.TO) experienced a 2.07% increase, closing at CA$9.36. This rise reflects investor optimism following the company's impressive financial results and market positioning in the medical technology sector.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$365.19M
52W high
$12.40
52W low
$5.23
1W change
-2.87%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 146.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+146.4% Upside
Current Price
C$10.16
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
42.5%
Annualized
90-Day Vol
82.2%
Annualized
Trend (90d)
+45.4%
Annualized drift
90d Mean
C$11.95
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$10.72 | C$9.26 โ C$12.42 |
| 60 trading days | C$11.32 | C$9.20 โ C$13.93 |
| 90 trading days | C$11.95 | C$9.26 โ C$15.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap of CA$339 million and strong revenue growth, Profound Medical is catching investors' attention, suggesting potential for further gains in the near future.
Profound Medical Corp's market cap reaches CA$339 million.
The 2.07% increase in stock price today reflects growing investor confidence as Profound Medical continues to report strong revenue growth.
Bull case
Profound Medical's recent financial results show a strong growth trajectory, with an 87% year-over-year revenue increase reported for Q3 2025. This impressive performance could attract more investors, driving the stock price even higher.
Bear case
Despite today's positive move, the companyโs negative profit margin of -2.07% raises concerns about its profitability and long-term sustainability, which might deter some risk-averse investors.
Strong Financial Performance
Profound Medical recently reported an impressive 87% year-over-year revenue increase for Q3 2025, reaching about CA$5.3 million. Such growth signals a positive trajectory for the company, making it an attractive option for investors looking for promising stocks in the healthcare sector.
Market Response and Future Outlook
The increase in stock price today reflects a favorable market response to Profound Medical's financial results. As the company prepares for upcoming presentations at major conferences, including the J.P. Morgan Healthcare Conference, investor interest is likely to remain strong, potentially leading to further gains.
Advertisement
